GlassScriptPhysician profile
Cathy Q Zhang
NPI 1508213539
$8,196.05
in general payments reported to CMS, 2019-2025
30 companies · $1,093 in 2025
The $1,093 reported for 2025 was more than what 94% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $220 · 2021: $1,112 · 2022: $3,021 · 2023: $2,303 · 2024: $447 · 2025: $1,093.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,160 · Travel and Lodging: $683.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,160.36 |
| Travel and Lodging | $682.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,411.02 | 2020-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Relievant Medsystems, INC. | $1,341.74 | 2022-2023 | Intracept |
| Spr Therapeutics, INC | $1,084.80 | 2022-2024 | Sprint Pns System |
| Spinal Simplicity, LLC | $959.46 | 2022-2024 | Ha Minuteman G3-R |
| Globus Medical, INC. | $668.90 | 2025 | Senza, Vyrsa V1 |
| Painteq LLC | $543.39 | 2022-2023 | Painteq |
| Nevro Corp. | $458.80 | 2022-2024 | Senza |
| Medtronic, INC. | $295.84 | 2021-2022 | |
| Virtus Pharmaceuticals LLC | $210.27 | 2023-2025 | Levorphanol Tartrate |
| Nalu Medical, INC. | $136.73 | 2023 | Nalu Neurostimulation System |
| Medtronic USA, INC. | $134.91 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $124.99 | 2021 | |
| Vertos Medical, INC. | $89.98 | 2023 | Mild Device Kit |
| Stimwave Technologies Incorporated | $77.50 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $76.19 | 2024-2025 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $67.41 | 2022-2025 | Eterna, Freestyle Libre |
| Esaote North America, INC. | $64.68 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $58.14 | 2023-2025 | Relistor |
| Horizon Therapeutics Plc | $57.79 | 2021-2022 | |
| Abbvie INC. | $51.94 | 2022-2023 | Ubrelvy |
| Novo Nordisk INC | $51.22 | 2022 | |
| Amgen INC. | $43.70 | 2022 | |
| Saluda Medical Americas, INC. | $36.56 | 2025 | Evoke |
| Smith+Nephew, INC. | $35.21 | 2025 | Collagenase Santyl |
| Fidia Pharma USA INC. | $27.50 | 2025 | Hymovis, Triluron |
| Novartis Pharmaceuticals Corporation | $22.73 | 2024 | |
| Lilly USA, LLC | $17.98 | 2025 | Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.54 | 2023 | Tradjenta, Jardiance |
| Curonix LLC | $16.80 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $12.33 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cathy Zhang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.